Clinical Trial Update: Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weekly gemcitabine in combination with trastuzumab for HER2-positive metastatic breast cancer has completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-03-12